K-tab
Drug - K-tab
The trade name of the product as shown on the labeling.
Dosage -
TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Potassium Chloride
Multiple ingredients are in alphabetical order.
Strength -
10MEQ
The potency of the active ingredient(s), Potassium Chloride. May repeat for multiple part products.
Applicant -
ABBOTT
The firm name holding legal responsibility for K-tab. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
018279
The FDA assigned number to K-tab. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify K-tab. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
BC
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Approved Prior to Jan 1, 1982
The date K-tab was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of K-tab. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs K-tab is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Abbott Laboratories Pharmaceutical Products Div
The full name of the firm holding legal responsibility for the new application of K-tab.
K-tab
Klor-con 8meq Tablet, Extended Release; Oral Klor-con M10 10meq Tablet, Extended Release; Oral Klor-con M15 15meq Tablet, Extended Release; Oral Klor-con M20 20meq Tablet, Extended Release; Oral Klotrix 10meq Tablet, Extended Release; Oral K-tab 10meq Tablet, Extended Release; Oral Kaon Cl-10 10meq Tablet, Extended Release; Oral K-dur 10 10meq Tablet, Extended Release; Oral K-dur 20 20meq Tablet, Extended Release; Oral Klor-con 10meq Tablet, Extended Release; Oral
NewDrugInformation
|